back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-10-14 Tx date 2016-10-11 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,800
-20,000 vol $1.54 each |
2,125,425 | |
| Filed 2016-10-07 Tx date 2016-10-05 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,400
-20,000 vol $1.42 each |
2,145,425 | |
| Filed 2016-10-07 Tx date 2016-10-05 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,200
-20,000 vol $1.41 each |
2,165,425 | |
| Filed 2016-10-07 Tx date 2016-10-05 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,000
-20,000 vol $1.35 each |
2,185,425 | |
| Filed 2016-09-02 Tx date 2016-08-29 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
350,000 | |
| Filed 2016-07-29 Tx date 2016-07-26 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,125
-2,500 vol $0.45 each |
2,207,925 | |
| Filed 2016-07-29 Tx date 2016-07-27 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,125
-2,500 vol $0.45 each |
2,205,425 | |
| Filed 2016-03-18 Tx date 2016-03-18 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
2,210,425 | |
| Filed 2016-03-04 Tx date 2016-01-10 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2015-08-07 Tx date 2015-07-30 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,263
+60,372 vol $0.17 each |
2,160,425 | |
| Filed 2015-07-10 Tx date 2015-07-08 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,000
-20,000 vol $0.20 each |
2,100,053 | |
| Filed 2015-06-01 Tx date 2015-05-29 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,100
-10,000 vol $0.21 each |
2,120,053 | |
| Filed 2015-05-11 Tx date 2015-05-07 |
$SL
Supreme Pharmaceuticals Inc. |
Herburger, Sarah
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,200
-10,000 vol $0.22 each |
2,130,053 |